Innovative treatment for Parkinson's disease: microscopic particles combined with light therapy offer a non-surgical solution ...

With support from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health (OASH), the National Institutes of Health (NIH) is leading the implementation of ...

This free half-day event will feature three panels of subject matter experts discussing the latest advancements in ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms ...

Dr Moukheiber also pointed out several "prodromal symptoms" of Parkinson’s disease, which can appear ... these could be early signs of Parkinson’s. Dr Moukheiber, who has been treating ...